Navigation Links
Gerresheimer Expands its Pharmaceutical Plastic Operations Into Southern Europe and South America
Date:12/21/2007

Consistent Continuation of Globalisation Path and Extension of Product

Offerings

DUSSELDORF, Germany, December 21 /PRNewswire-FirstCall/ -- Gerresheimer AG is consistently continuing its strategy of globalisation and extension of product offerings in the pharma and life-science sector. With the acquisition of the Spanish company EDP S.A. it gains a leading manufacturer of pharmaceutical plastic packaging which contributes to the Group a total of three plants in Southern Europe and South America. "Regional expansion opens up important new growth markets for our Plastic Systems Division. At the same time, EDP ideally complements our existing product portfolio thus offering globally exploitable synergies," comments Gerresheimer CEO Dr. Axel Herberg. The transaction is expected to be completed at the end of January 2008.

As a leading specialist for pharmaceutical primary packaging and application systems, Gerresheimer has for a considerable time enjoyed a strong position with glass products like syringe systems and pharmaceutical vials; in parallel it has expanded its pharmaceutical and medical plastics business, so far in Europe particularly. The acquisition of the new company specialising in plastic substantially expands its sphere of activity in this segment.

EDP with production plants in Spain (Zaragoza and Valencia) and Argentina (Buenos Aires) concentrates on PET containers for the pharmaceutical industry and is the market leader in this important field. This company's annual sales total around EUR32m.

The products of the EDP company provide an ideal match, which will by no means be limited to the local markets. Pharma packaging based on PET, as produced by EDP in Spain and Argen­tina, represents a real range expansion, which Gerresheimer can complement with drug delivery systems to provide a system approach. At the same time, the Spanish and South American markets of the new subsidiary are opened up for innovative packaging and system technologies from existing Gerresheimer plants. Gerresheimer's pharmaceutical plastics business ranks among the market leaders, so far in Europe particularly.

As Herberg stresses, full integration of the new company into the Group is to be completed in the first half of 2008. The new subsidiary currently achieves an EBITDA margin of around 17%. Through targeted technical and financial optimisation measures the EBITDA margin should be increased to well above 20%.

About Gerresheimer

Gerresheimer employs around 10,000 people in 37 locations across Europe, America and Asia. The Group's product range extends from glass and plastic medicine bottles to complex drug-delivery systems for the pharma and life-science industries. The product spectrum includes sterile syringes, inhalers and other system-based solutions for safer dosage and delivery of medications. The Group enjoys a leading position in a market which is characterised by high technical and regulatory barriers and where Gerresheimer's products must satisfy the strictest quality standards of the international pharmaceutical supervisory bodies. The Group achieves worldwide sales of more than EUR950m.

Contact

Burkhard Lingenberg

Director Corporate PR & Marketing

Telephone: +49-211-6181-250

Telefax: +49-211-6181-241

e-mail: b.lingenberg@gerresheimer.com

Internet: http://www.gerresheimer.com


'/>"/>
SOURCE Gerresheimer AG
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Gerresheimer to be Included in the SDAX Early Decision on Inclusion in the MDAX on September 5, 2007
2. Growth Trend for Gerresheimer Continues Unabated - Debt Reduction
3. Linnartz New Head of Investor Relations of Gerresheimer
4. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
5. Rohm and Haas Expands in India
6. Concentra Expands Horizon Air Employee Health Program With On-Site Clinic
7. Regional Center of Orange County Expands Family Support Resources to Meet Growing Needs
8. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
9. Specialty Blades, Inc. Expands Management Team With New VP Engineering
10. CRH Medical expands Las Vegas operations
11. US Med-Equip Expands Corporate Support Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... January 23, 2017 , ... ... companies, has achieved ISO 17100:2015 certification following a comprehensive audit performed by ... globally recognized standard that establishes guidance for critical processes within translation, quality ...
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... ... the highly acclaimed series, Innovations with Ed Begley, Jr., scheduled to broadcast Saturday, ... technology behind SmartCap, which was founded in 2008 to address the limitations of ...
(Date:1/23/2017)... FL (PRWEB) , ... January 23, 2017 , ... Wooden and plastic balance boards have ... strength and improve balance. Kumo Board is the first and only balance board ... it to be soft and rigid at the same time as well as skill-level adjustable ...
(Date:1/23/2017)... ... January 23, 2017 , ... Sharon Kleyne, America’s leading water researcher, advocate ... about the benefits of making new water infrastructure a number one priority. “As we ... we expect water infrastructure to become a top priority of our new political change ...
(Date:1/23/2017)... ... 23, 2017 , ... Zachary Cattell, President of the Indiana ... industry expert at the 2017 Sector Summit hosted by Ivy Tech Community College ... Gerry Dick, will feature an employer and an association representative from five of ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... January 23, 2017 Varias ... enal) y el riesgo de ... a pabetalone    Resverlogix Corp. ("Resverlogix" ... preliminares de un ensayo en fase 1 con sede ... riñón (renal) severa. Los datos demostraron unos resultados importantes ...
(Date:1/23/2017)... January 23, 2017 Longer life expectancy and rising ... global market for medical device technologies. BCC Research reveals in ... Asia-Pacific region, should see strong growth due to rising ... incomes. Continue Reading ... ...
(Date:1/23/2017)... PALMA, Spain , January 23, ... a clinical-stage biopharmaceutical company focused on treatments for ... has been enrolled in the Phase IIb "CaLIPSO ... the treatment of cardiovascular calcification (CVC) in end-stage-renal-disease ... ESRD patients, in the last stage of chronic ...
Breaking Medicine Technology: